SCHEMBL7370288

SCHEMBL7370288

COC(=O)c1cc(Cl)c(C(C)(C)O)s1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 4/20 0.41
L3MBTL1 Q9Y468 4/20 0.41
MAPK1 P28482 3/20 0.41
NPSR1 Q6W5P4 3/20 0.41
TSHR P16473 1/20 0.41
ATM Q13315 1/20 0.41
ALDH1A1 P00352 4/20 0.40
KDM4E B2RXH2 3/20 0.40
NPC1 O15118 2/20 0.40
RAB9A P51151 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
CCNC P24863 1/20 0.39
CDK8 P49336 1/20 0.39
DAO P14920 1/20 0.39
CTPS1 P17812 1/20 0.39
MRGPRX4 Q96LA9 1/20 0.39
CSNK2A2 P19784 1/20 0.39
KDR P35968 1/20 0.39
CSNK2B P67870 1/20 0.39
CSNK2A1 P68400 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21633836 0.85 ALDH1A1 (0.48) HPGDL3MBTL1MAPK1NPSR1TSHR
SCHEMBL7370065 0.81 ICAM1 (0.45) RAB9ACCNCCDK8DAOCSNK2A2
SCHEMBL20892550 0.75 MRGPRX4 (0.43) HPGDL3MBTL1MAPK1NPSR1TSHR
SCHEMBL22607818 0.72 MRGPRX4 (0.39) HPGDL3MBTL1MAPK1NPSR1TSHR
SCHEMBL7373186 0.71 RAF1 (0.46) HPGDL3MBTL1MAPK1NPSR1TSHR
SCHEMBL23022514 0.71 CSNK2A2 (0.41) HPGDL3MBTL1MAPK1NPSR1TSHR
SCHEMBL22021189 0.71 MCL1 (0.45) HPGDL3MBTL1MAPK1NPSR1TSHR
SCHEMBL23531570 0.71 KDM4E (0.39) HPGDL3MBTL1MAPK1NPSR1TSHR
SCHEMBL24978772 0.71 MCL1 (0.45) HPGDL3MBTL1MAPK1NPSR1ALDH1A1
SCHEMBL18490305 0.70 PTPN2 (0.45) HPGDL3MBTL1MAPK1NPSR1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6380218-B1 FOR THERAPY OF RESPIRATORY, ALLERGIC, AND INFLAMMATORY DISORDERS COMPRISING ASTHMA, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, ACUTE RESPIRATORY DISEASE SYNDROME, PULMONARY HYPERSENSITIVITY, AND ALLERGIC RHINITIS IN A MAMMAL PFIZER INC 2002-04-30 US disclosed
CN-1254335-A Nicotinamide derivatives PFIZER PROD INC (US) 2000-05-24 CN disclosed
EP-0971894-A1 NICOTINAMIDE DERIVATIVES Pfizer Products Inc. (US) 2000-01-19 EP disclosed
WO-1998045268-A1 NICOTINAMIDE DERIVATIVES PFIZER PRODUCTS INC. (US) 1998-10-15 WO disclosed